FDA Inspection 1252745 - Actelion Pharmaceuticals US Inc. - October 28, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Actelion Pharmaceuticals US Inc., with an inspection on October 28, 2024, issued by the New Jersey District Office, covering human drugs.

Company: Actelion Pharmaceuticals US Inc.
Inspection Date: October 28, 2024
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 42933576-b78e-47aa-9776-8c1f99b939b9

Violation Codes2

FD&C Act 505-1(f)(4)FDCA 505-1(f)(3)(B)

Full citation text and observation details available on the Dashboard.